1. Bharati J, Bhatia D, Khandelwal P, Gupta N, Sinha A, Khadgawat R, Hari P,Bagga A. C-Terminal Fibroblast Growth Factor-23 Levels in Non-Nutritional Hypophosphatemic Rickets. The Indian J Pediatr. Mar 5, 2019.
2. Akchurin O, Patino P, Dalal V, Meza K, Bhatia D, Brovender S, Zhu YS, RundlesSC, Perelstein E, Kumar J, Rivella S, Choi ME. Interleukin-6 contributes to thedevelopment of anemia in juvenile chronic kidney disease. KidneyInternational Rep. Dec. 2018.
3. Pabon M, PatinoE, Bhatia D, Quintero JR, Ma K, Finkelsztein E, Osorio J, MalickF, Polverino F, Owen C, Ryter SW, Choi AMK, Cloonan S, Choi ME. Beclin-1 Regulates Cigarette Smoke-Induced Kidney Injury in a Murine Model of Chronic Obstructive Pulmonary disease. JCI Insight.August, 2018.
4. Bhatia D,SinhaA, Hari P, Sopory S, Saini S, Puraswani M, Sani H, Mitra DK, Bagga A. Rituximab modulates T and B lymphocyte subsets and urinary CD80 excretion inpatients with steroid-dependent nephrotic syndrome. Pediatric Research, July 2018.
5. Ryter SW, BhatiaD and Choi ME. Autophagy: a Lysosome-Dependent Process with Implications in Cellular Redox Homeostasis and Human Disease. Antioxidants& Redox Signaling.Feb., 2018.
6. Khandelwal P*, BirlaS*, Bhatia D*, Puraswani M, Saini H., Sinha A., Hari P., SharmaA.,Bagga A. *Authors contributed equally. Mutations in membrane cofactor protein (CD46) gene in Indian children with hemolytic uremicsyndrome. Clin Kid Journal,August, 2017.
7. Sinha A, BhatiaD, Gulati A, Rawat M, Dinda AK, Hari P, Bagga A. Efficacy and safety ofrituximabin children with difficult-to-treat nephrotic syndrome. Nephrol. Dial.Transplant. Jan., 2015.
8. Bhatia D, KhandelwalP, Sinha A, Hari P, Cheong HI, Bagga A. Incomplete penetrance of CD46 mutation causing familial atypical hemolytic uremic syndrome. Pediatr Nephrol. Dec., 2015.
9. Sinha A, Gulati A,Saini S, Blanc C, Gupta A,Gurjar BS, Saini H, Kotresh ST, Ali U, Bhatia D et al. Prompt plasma. exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children. Kidney Int., May, 2014.
10. Sinha A, Bajpai J, Saini S, Bhatia D, Gupta A, Puraswani M,Dinda AK, Agarwal SK, SaporyS, Pandey RM, Hari P, Bagga A. Serum soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children. Kidney Int. March,2014.
Accepted/submitted:
11. ChungKP, Hsu CL, Fan LC, HuangZ, Bhatia D,Chen YJ, Hisata S, Cho SJ, Nakahira K, Imamura M, ChoiME, Yu CJ, Cloonan SM,and Choi AMK. Mitofusins Regulate Lipid Metabolism toMediate the Development of Lung Fibrosis. Accepted by Nature Communications.
12. Bhatia D,Chung KP, Nakahira K, Patino E, Rice M, Torres L, Muthukumar T, Choi AMK, Akchurin O, Choi ME. Mitophagy Dependent Macrophage Reprogramming Protects against Kidney Fibrosis. Under consideration by the Journal of Clinical Investigation (submitted on June 24, 2019).